There is compelling evidence that the elevated plasma lipoprotein (a)[Lp (a)] levels increase
the risk of atherosclerotic cardiovascular disease (ASCVD) in the general population. Like …

Background Carotid artery atherosclerotic stenosis is a preventable major cause of stroke,
but there is still a need for definition of high-risk plaque in asymptomatic patients who might …

Abstract Purpose of Review Familial hypercholesterolemia (FH) and hyperlipoproteinemia
(a) are relatively common disorders, posing a significant health burden due to increased risk …

Lipoprotein (a)(Lp (a)) is a low density lipoprotein particle that is associated with poor
cardiovascular prognosis due to pro-atherogenic, pro-thrombotic, pro-inflammatory and pro …

Abstract Lipoprotein (a)[Lp (a)] is a highly heritable cardiovascular risk factor. Although
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …

The aim of this meta-analysis of randomized placebo-controlled clinical trials was to assess
the effect of ezetimibe on plasma lipoprotein (a) concentrations. Only randomized placebo …

Abstract Plasma lipoprotein (a)[Lp (a)] elevations are associated with increased
cardiovascular risk. Coenzyme Q 10 (CoQ 10) is a member of the mitochondrial respiratory …

Previously, our group found that the dietary trace mineral element selenium and vitamin B 6
(VitB 6) alone was involved in lipid metabolism. However, the effects of selenium combined …

Background An elevated lipoprotein (a)(Lp (a)) level is observed in more than 30% of
patients with stable ischemic heart disease (SIHD). We conducted an investigation of the …

Cardiovascular disease (CVD) has consistently been the leading cause of death worldwide.
Several clinical and epidemiological studies have demonstrated that an elevated plasma …